Turning Cell Signaling against Cancer
Researchers Use Single-Molecule Assays, Splice-Switching Oligonucleotides, and Fusion Constructs
Improvements to Gene Therapy Clinical Trial Design Benefit Hemophilia Patients
Gene Therapy Allows Hemophilia Patients to Give Up Medication, Avoid Bleeds; but More Improvements Are Needed
Supplement: Applications of Novel CRISPR Tools
Experts in the Field Speak to the Ways CRISPR Is Used
Virus Supply Vexes Gene Therapy Developers, CMOs
Some Contract Manufacturing Organizations Are Ramping Up Capacity in Preparation for a Boom in Viral Vector Demand
For full access to this article login to GEN Select now.
Roslin Cells & Lonza Take On Stem Cell Media
Ultimate Goal of Initiatives Is to Facilitate Translation of Innovation into Regenerative Therapies
- Earlier this year Roslin Cells and Lonza signed a stem cell media development deal the firms hope will play a key role in the drive to translate scientific innovation in the stem cells field into clinically applied regenerative therapies. The agreement is centered on the development of clinical-grade ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.